Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ING2 | Q9H160 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | CASP6 | P55212 | 3/20 | 0.42 |
| ▸ | NSD2 | O96028 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 3/20 | 0.41 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL7092779 | 0.95 | ING2 (0.50) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL7590808 | 0.93 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL7088257 | 0.89 | ING2 (0.45) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL30057851 | 0.88 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL29367149 | 0.88 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL30999 | 0.88 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL8516658 | 0.88 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL9242875 | 0.88 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL772208 | 0.88 | ING2 (0.48) | ING2LCKFYNLMNAALDH1A1 | |
| SCHEMBL9960463 | 0.86 | ING2 (0.47) | ING2LCKFYNLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6649753-B2 | S-adenosyl-L-methionine derivative for use in the treatment of brain disorders | ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) | 2003-11-18 | — | — | US | claimed |
| US-12112900-B2 | Electrolytic capacitor | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-10-08 | — | — | US | disclosed |
| WO-2024129953-A1 | ESTERIFICATION OF ALPHA-GLUCAN COMPRISING ALPHA-1,6 GLYCOSIDIC LINKAGES | Nutrition & Biosciences USA 4, Inc. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024129951-A1 | ESTERIFICATION OF ALPHA-GLUCAN COMPRISING ALPHA-1,6 GLYCOSIDIC LINKAGES | Nutrition & Biosciences USA 4, Inc. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024015769-A1 | AMPHIPHILIC GLUCAN ESTER DERIVATIVES | Nutrition & Biosciences USA 4, Inc. (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2023114942-A1 | COMPOSITIONS COMPRISING CATIONIC ALPHA-GLUCAN ETHERS IN AQUEOUS POLAR ORGANIC SOLVENTS | Nutrition & Biosciences USA 4, Inc. (US) | 2023-06-22 | — | — | WO | disclosed |
| EP-4168457-A1 | CATIONIC POLY ALPHA-1,6-GLUCAN ETHERS AND COMPOSITIONS COMPRISING SAME | Nutrition & Biosciences USA 4, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| EP-4165091-A1 | POLY ALPHA-1,6-GLUCAN ESTERS AND COMPOSITIONS COMPRISING SAME | Nutrition & Biosciences USA 4, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-4165090-A1 | POLY ALPHA-1,6-GLUCAN DERIVATIVES AND COMPOSITIONS COMPRISING SAME | Nutrition & Biosciences USA 4, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| US-20220344105-A1 | ELECTROLYTIC CAPACITOR | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2022-10-27 | — | — | US | disclosed |
| US-6649753-B2 | S-adenosyl-L-methionine derivative for use in the treatment of brain disorders | ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) | 2003-11-18 | — | — | US | disclosed |
| US-20030032796-A1 | New stable salts of S-adenosyl-L-methionine (SAMe) and the process for their preparation | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED, INDIA | 2003-02-13 | — | — | US | disclosed |
| WO-2002102823-A1 | STABLE SALTS OF S-ADENOSYL-L-METHIONINE (SAME) AND THE PROCESS FOR THEIR PREPARATION | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2002-12-27 | — | — | WO | disclosed |
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
| EP-1123376-A2 | LAUNDRY AND CLEANING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-16 | — | — | EP | disclosed |
| US-6114512-A | REACTING A TETRAZOTIZED DIAMINE COMPOUND WITH A COUPLING COMPOUND CONTAINING AMINONAPHTHOL-MONO OR DI-SULFONIC ACID COMPOUND TO FORM TETRAAZO DYE | BASF AKTIENGESELLSCHAFT (DE) | 2000-09-05 | — | — | US | disclosed |
| WO-2000002982-A2 | LAUNDRY AND CLEANING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-20 | — | — | WO | disclosed |
| CN-1146779-A | Polyhydroxy amides to provide dye transfer inhibition benefits during fabric laundering | PROCTER & GAMBLE (US) | 1997-04-02 | — | — | CN | disclosed |
| US-4933399-A | COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1990-06-12 | — | — | US | disclosed |
| EP-0320227-A2 | Method of preventing polymer-scale formation | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | ING2 2180/4885LCK 4194/4885FYN 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.